re: Ann: Pharmaxis Announces Positive Combine... Once approved Pharmaxis are aiming for sales of Bronchitol to match those of Pulmozyme which were $460 million USD in 2009.
If they can do this we are looking at a share price many times higher than what we have today.
I think once european approval is granted we will see further share price appreciation.
wiljon.
Ann: Pharmaxis Announces Positive Combined Phase , page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
